| CAS ID: | 1015787-98-0 |
| Molecular Formula: | C14H19N5O4S |
| Molecular Weight: | 353.4 g/mol |
| Monoisotopic Mass: | 353.1158 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | RG1646 | R1646 | RO4926219 | AF-219 | GEFAPIXANT |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02477709 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | June 23, 2015 | Last Verified | May 16, 2017 |
| Sponsor | Afferent Pharmaceuticals, Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT02502097 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | July 20, 2015 | Last Verified | May 31, 2017 |
| Sponsor | Afferent Pharmaceuticals, Inc. | ||
| PubChem: | 24764487 |
| ChEMBL: | CHEMBL3716057 |